First results of NURE-Combo: A phase 2 study of neoadjuvant Nivolumab (NIVO) and Nab-Paclitaxel (ABX) followed by postsurgical adjuvant NIVO in patients (pts) with Muscle-Invasive Bladder Cancer (MIBC)

Saved in:
Bibliographic Details
Published in:European urology 2024-03, Vol.85, p.S1951
Main Authors: Mercinelli, C., Basile, G., Raggi, D., Cigliola, A., Tateo, V., Patanè, D.A., Crupi, E., Costa De Padua, T., Colecchia, M., Colombo, R., Moschini, M., Re, C., Avesani, G., Brembilla, G., De Cobelli, F., Briganti, A., Pavlick, D.C., Ross, J.S., Montorsi, F., Necchi, A.
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0302-2838
DOI:10.1016/S0302-2838(24)01471-4